0001209191-23-045229.txt : 20230809
0001209191-23-045229.hdr.sgml : 20230809
20230809180536
ACCESSION NUMBER: 0001209191-23-045229
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230807
FILED AS OF DATE: 20230809
DATE AS OF CHANGE: 20230809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neumann Mark
CENTRAL INDEX KEY: 0001756211
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 231156560
MAIL ADDRESS:
STREET 1: C/O INTRA-CELLULAR THERAPIES, INC.
STREET 2: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-07
0
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001756211
Neumann Mark
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK
NY
10016
0
1
0
0
EVP, Chief Commercial Officer
0
Common Stock
2023-08-07
4
M
0
55300
18.59
A
100639
D
Common Stock
2023-08-07
4
S
0
55300
58.79
D
45339
D
Stock Option (right to buy)
18.59
2023-08-07
4
M
0
55300
0.00
D
2028-10-14
Common Stock
55300
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.3319 to $59.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
All shares underlying this option have vested.
/s/ Lawrence J. Hineline, Attorney-in-fact
2023-08-09